Who owns Regeneron Pharmaceuticals (REGN)? Superinvestor holders

10 superinvestors of the 157 tracked here hold Regeneron Pharmaceuticals (REGN) in their latest 13F filing, with $5.7B between them. Mason Hawkins gives it the most weight: 4.95% of the reported portfolio.

Hold it now
10
of 157 tracked
Combined value
$5.7B
Bought / sold
5 / 5
last quarter

Key facts

Superinvestors holding it
10 of 157
Biggest holder
Dodge & Cox team, $3.6B
Largest weight
Mason Hawkins, 4.95%of their portfolio
Combined value
$5.7B
Bought last quarter
5
Sold last quarter
5

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding REGN, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Mason HawkinsSoutheastern Asset Management (Longleaf)4.95%$95M152.32K▲ Added 17%+21.66KQ2 2026
2Harry BurnSound Shore Management2.99%$95.7M126.18K▼ Reduced 0.6%−813Q3 2026
3Dodge & Cox teamDodge & Cox1.94%$3.6B4.77M▼ Reduced 2.0%−96.44KQ3 2026
4John Overdeck and David Siegel (founders)Two Sigma Investments0.48%$659.3M869.51K▲ Added 33%+213.37KQ3 2026
5Josef LakonishokLSV Asset Management0.35%$186.6M246.13K▼ Reduced 2.8%−7.06KQ3 2026
6Jim Simons (1938–2024)Renaissance Technologies0.28%$206.4M272.22K▲ Added 84%+124KQ3 2026
7Cliff AsnessAQR Capital Management0.25%$702.2M1.13M▼ Reduced 8.5%−104.88KQ2 2026
8Joel GreenblattGotham Asset Management0.15%$65.6M105.17K▲ Added 27%+22.32KQ2 2026
9Ray Dalio (founder)Bridgewater Associates0.13%$32M51.33K▲ Added 126%+28.61KQ2 2026
10Jeremy Grantham (co-founder)GMO (Grantham, Mayo, Van Otterloo)0.12%$53.9M71.08K▼ Reduced 4.2%−3.12KQ3 2026

Quarter by quarter

Superinvestor ownership of REGN by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269266.36M$4.8B24
Q2 202615797.42M$4.6B64
Q1 202615787.12M$5.5B47
Q4 2025157137.73M$6B94
Q3 2025157137.88M$4.4B95
Q2 2025157106.53M$3.4B74
Q1 202515693.74M$2.4B90
Q4 202415673.38M$2.4B45

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of REGN held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Dodge & Cox team4.77M4.87M4.46M4.6M4.55M3.83M2.32M2.32M
John Overdeck and David Siegel (founders)869.51K656.12K812.24K281.15K469.9K499.83K372.07K—
Jim Simons (1938–2024)272.22K———275.16K——247.74K
Josef Lakonishok246.13K253.2K196.28K166.51K————
Harry Burn126.18K126.99K150.96K175.89K115.03K———
Jeremy Grantham (co-founder)71.08K74.2K55.35K56.7K61.47K65.28K83.33K62.98K
Cliff Asness·1.13M1.23M995.71K721.35K——207.09K
Mason Hawkins·152.32K130.66K165.79K144.61K160.58K114.88K—
Joel Greenblatt·105.17K82.85K80.27K84.23K—32.05K—
Ray Dalio (founder)·51.33K—72.75K235.38K89.05K——
Brandon Haley·——460.72K151.73K———
Israel Englander·——379.77K—338.83K——
Steve Cohen·——262.53K201.5K———
Robert Pitts·——35.2K————
David Shaw (founder)·———861.59K777.47K578.89K500.23K
Cathie Wood————12.14K12.61K13.69K13.19K
Ken Griffin·————680.51K——
Paul Tudor Jones·————84.55K126.09K28.57K
Andreas Halvorsen·—————97.74K—

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own REGN?

In their latest 13F filings: Mason Hawkins (4.95% of the portfolio, $95M), Harry Burn (2.99% of the portfolio, $95.7M), Dodge & Cox team (1.94% of the portfolio, $3.6B), John Overdeck and David Siegel (founders) (0.48% of the portfolio, $659.3M), Josef Lakonishok (0.35% of the portfolio, $186.6M), Jim Simons (1938–2024) (0.28% of the portfolio, $206.4M), Cliff Asness (0.25% of the portfolio, $702.2M), Joel Greenblatt (0.15% of the portfolio, $65.6M), and 2 more.

Who bought REGN last quarter?

Mason Hawkins (added 17%), John Overdeck and David Siegel (founders) (added 33%), Jim Simons (1938–2024) (added 84%), Joel Greenblatt (added 27%), Ray Dalio (founder) (added 126%). “Last quarter” is each investor's latest reported quarter.

Who sold REGN last quarter?

Reduced: Harry Burn (0.6% fewer shares), Dodge & Cox team (2.0% fewer shares), Josef Lakonishok (2.8% fewer shares), Cliff Asness (8.5% fewer shares), Jeremy Grantham (co-founder) (4.2% fewer shares).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Regeneron Pharmaceuticals (REGN)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/REGN/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to REGN by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.